IMV Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
25 July 2018 - 9:05PM
IMV Inc. (Nasdaq:IMV) (TSX:IMV), a clinical stage immuno-oncology
corporation, today announced that IMV Chief Executive Officer
Frederic Ors will present a corporate update at the Canaccord
Genuity 38th Annual Growth Conference, which takes place August
8-9, 2018, in Boston, MA.
IMV’s presentation details include:
- Date: Wednesday, August 8, 2018
- Time: 10:30 – 10:55 a.m. ET
- Location: Melbourne Room at the
Intercontinental Hotel, Boston, MA
There will be a live webcast of IMV’s presentation accessible at
http://wsw.com/webcast/canaccord30/imv/. The webcast will be
archived for 90 days following the live presentation. A copy of the
presentation will be available on the Events & Presentations
page of IMV’s website: www.imv-inc.com.
About IMV
IMV Inc., formerly Immunovaccine Inc., is a clinical stage
biopharmaceutical company dedicated to making immunotherapy more
effective, more broadly applicable, and more widely available to
people facing cancer and other serious diseases. IMV is pioneering
a new class of immunotherapies based on the Company’s proprietary
drug delivery platform. This patented technology leverages a novel
mechanism of action that enables the programming of immune cells in
vivo, which are aimed at generating powerful new synthetic
therapeutic capabilities. IMV’s lead candidate, DPX-Survivac, is a
T cell-activating immunotherapy that combines the utility of the
platform with a target: survivin. IMV is currently assessing
DPX-Survivac as a combination therapy in multiple clinical studies
with Incyte and Merck. Connect at www.imv-inc.com.
Contacts for
IMV:MEDIA Mike Beyer, Sam
Brown Inc.T: (312) 961-2502 E: mikebeyer@sambrown.com
INVESTOR RELATIONSPierre Labbé, Chief
Financial OfficerT: (902) 492-1819 E: info@imv-inc.com
Patti Bank, Managing Director, Westwicke
PartnersO: (415) 513-1284T: (415) 515-4572 E:
patti.bank@westwicke.com
IMV (TSX:IMV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMV (TSX:IMV)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about IMV Inc (Toronto Stock Exchange): 0 recent articles
More News Articles